{
    "Trade/Device Name(s)": [
        "ACRO HCG Pregnancy Rapid Test"
    ],
    "Submitter Information": "Acro Biotech, Inc.",
    "510(k) Number": "K180771",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172512"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "May 18, 2018",
    "Summary Letter Received Date": "March 23, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow chromatographic immunoassay",
        "Sandwich immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Test",
        "Reagent",
        "Strip test",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for ACRO HCG Pregnancy Rapid Test, a lateral flow immunochromatographic urine assay for rapid detection of hCG to aid pregnancy diagnosis",
    "Indications for Use Summary": "Over-the-counter visual qualitative detection of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy using dip or midstream mode",
    "fda_folder": "Clinical Chemistry"
}